Concepedia

Benjamin E. Turk

BE

3

Publications

126

Citations

3

H-Index

1996

Active since

Affiliations

Massachusetts Institute of Technology(Current)

Center for Cancer Research

Benjamin E. Turk is an author at Massachusetts Institute of Technology specializing in pharmacotherapy, drug development, and immunology.

Top concepts

MedicineImmunologyInflammationPharmacologyDrug DiscoveryPharmacotherapyDrug DevelopmentMedicinal ChemistryDerivativesTumor Biology

Publications per year

1996–1998

3

Publications

3

Potent Inhibition of Tumor Necrosis Factor-α Production by Tetrafluorothalidomide and Tetrafluorophthalimides

Satomi Niwayama, Benjamin E. Turk, Jun O. Liu · Journal of Medicinal Chemistry · 1996 · 55 citations · Full text

Inflammation, Molecular Pharmacology, Medicinal Chemistry +15

Synthetic analogues of TNP-470 and ovalicin reveal a common molecular basis for inhibition of angiogenesis and immunosuppression

Benjamin E. Turk, Zhuang Su, Jun O. Liu · Bioorganic & Medicinal Chemistry · 1998 · 52 citations

Enhanced potency of perfluorinated thalidomide derivatives for inhibition of LPS-induced tumor necrosis factor-α production is associated with a change of mechanism of action

Satomi Niwayama, Christine Loh, Benjamin E. Turk et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 19 citations

Inflammation, Medicinal Chemistry, Anti-inflammatory +12

Rows per page

1–3 of 3